Literature DB >> 7694877

Sequential appearance of relaxin, prolactin and IGFBP-1 during growth and differentiation of the human endometrium.

G D Bryant-Greenwood1, E M Rutanen, S Partanen, T K Coelho, S Y Yamamoto.   

Abstract

Relaxin (RLX) is a product of the human corpus luteum, pregnancy decidua and placenta, prolactin (PRL) and insulin-like growth factor binding protein-1 (IGFBP-1) are products of the cyclic endometrium and of the pregnancy decidua. All three proteins are thought to function interdependently in endometrium/decidua as local factors within the uterus without reaching the systemic circulation. In this study, the avidin-biotin immunoperoxidase method for immunolocalization with monoclonal or polyclonal antibodies has been applied to serial sections of endometria obtained from patients at different stages of the menstrual cycle and in early and late gestation. This allowed the cellular localization of the three proteins to be followed simultaneously through the reproductive stages from cyclic endometrium to term gestational decidua. The production, as opposed to sequestration of RLX from an ovarian source was demonstrated by the application in parallel of an antibody to the processed hormone and its connecting peptide. RLX was shown localized to the glandular and luminal epithelia in the proliferative and secretory phases. The decidualized stromal cells also immunostained for RLX in the late secretory phase and in early and late pregnancy. PRL was localized first to the glandular epithelium and then stroma, appearing after RLX, IGFBP-1 appeared later in the secretory phase and predominantly in the decidualized stromal cells confirming previous studies. In contrast, all three proteins were immunostained in early pregnancy and increased to term gestation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694877     DOI: 10.1016/0303-7207(93)90025-f

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  N5 endometrial stromal cell line: a model system to study decidual prolactin gene expression.

Authors:  A K Brar; Y Kanda; C A Kessler; M I Cedars; S Handwerger
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-03       Impact factor: 2.416

2.  A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus.

Authors:  Magali Ancelin; Hélène Buteau-Lozano; Geri Meduri; Mary Osborne-Pellegrin; Sylvie Sordello; Jean Plouët; Martine Perrot-Applanat
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

Review 3.  G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention.

Authors:  Kirk P Conrad
Journal:  Hum Reprod Update       Date:  2016-07-06       Impact factor: 15.610

4.  Trends in serum relaxin concentration among elite collegiate female athletes.

Authors:  Jason L Dragoo; Tiffany N Castillo; Tatiana A Korotkova; Ashleigh C Kennedy; Hyeon Joo Kim; Dennis R Stewart
Journal:  Int J Womens Health       Date:  2011-01-19

Review 5.  Biology of primate relaxin: a paracrine signal in early pregnancy?

Authors:  Eric S Hayes
Journal:  Reprod Biol Endocrinol       Date:  2004-06-16       Impact factor: 5.211

6.  Relaxin deficiency results in increased expression of angiogenesis- and remodelling-related genes in the uterus of early pregnant mice but does not affect endometrial angiogenesis prior to implantation.

Authors:  Sarah A Marshall; Leelee Ng; Elaine N Unemori; Jane E Girling; Laura J Parry
Journal:  Reprod Biol Endocrinol       Date:  2016-03-22       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.